Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review

OBJECTIVES: First, to investigate if switching biological disease-modifying antirheumatic drugs (bDMARDs) after the failure to prior bDMARD is efficacious in patients with axial spondyloarthritis (axSpA). Second, to evaluate the influence on this efficacy of (1) the reason to discontinue prior tumou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:RMD Open
Egile Nagusiak: Navarro-Compán, Victoria, Plasencia-Rodríguez, Chamaida, de Miguel, Eugenio, Diaz del Campo, Petra, Balsa, Alejandro, Gratacós, Jordi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2017
Gaiak:
Spondyloarthritis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5640114/
https://ncbi.nlm.nih.gov/pubmed/29071119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000524
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak